Wolfgang Grosse

Title: Wolfgang Grosse - Innovator in Flavivirus Vaccine Development

Introduction

Wolfgang Grosse is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of virology, particularly in the development of vaccines against flavivirus infections. His innovative work has the potential to impact public health positively.

Latest Patents

Wolfgang Grosse holds 1 patent related to a flavivirus vaccine. This invention focuses on an artificial nucleic acid and a polypeptide that are suitable for the treatment or prevention of infections caused by flaviviruses, such as yellow fever virus and dengue virus. The patent also includes an immunogenic composition that comprises the artificial nucleic acid or the inventive polypeptide. Furthermore, it outlines a method for treating or preventing disorders related to flavivirus infections.

Career Highlights

Throughout his career, Wolfgang Grosse has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with CureVac SE and Sanofi Pasteur Inc. His work in these organizations has contributed to advancements in vaccine development and infectious disease management.

Collaborations

Wolfgang Grosse has collaborated with several professionals in his field, including Patrick Baumhof and Edith Jasny. These collaborations have likely enhanced the scope and impact of his research and innovations.

Conclusion

Wolfgang Grosse's contributions to flavivirus vaccine development exemplify the importance of innovation in addressing global health challenges. His work continues to pave the way for advancements in vaccine technology and infectious disease prevention.